Biogen amends bylaws to update stockholder notice requirements and align with SEC universal proxy rules

BIOGEN INC.

Requires disclosure of derivative/synthetic long positions from stockholders proposing business or nominations.
Aligns director nomination procedures with Rule 14a-19, including 67% proxy solicitation representation requirement.
Limits number of nominees a stockholder may propose to number of directors to be elected at meeting.
Requires stockholder proxy solicitations to use non-white proxy cards; white cards reserved for Board use.
Updates adjournment, quorum, and stockholder list provisions to conform to recent Delaware law changes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.